Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$12,867,347
+$655,868 QoQ
Shares Held
100,135
-1.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#654
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. MRK ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
59,835 | $3,447,692 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,867,347 | 100,135 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $12,211,479 | 101,517 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $10,819,254 | 102,786 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $10,048,854 | 119,729 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,502,603 | 120,043 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,383,584 | 93,400 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $5,846,638 | 58,772 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $6,894,908 | 60,716 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,150,811 | 57,761 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,894,783 | 52,253 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $5,615,075 | 51,505 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $4,454,028 | 43,264 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,953,115 | 42,925 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,874,045 | 45,813 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $5,054,438 | 45,556 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,052,032 | 47,051 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $4,382,086 | 48,065 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,871,529 | 47,185 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $4,062,226 | 53,004 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $3,588,154 | 47,772 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $3,552,533 | 45,680 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,037,887 | 39,407 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $3,175,147 | 38,816 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,480,343 | 66,068 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,446,103 | 31,632 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $295,449 | 3,840 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||